Primary Record
asciminib
- In stock
- 2,575 g
- Purity
- 99.0 %
- CAS
- 1492952-76-7
Compound Identifiers & Properties
- CAS
- 1492952-76-7
- PubChem CID
- 72165228
- SMILES
- C1CN(C[C@@H]1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4
- Canonical SMILES
- O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2ccn[nH]2)c1
Names & Synonyms
- asciminib
- Scemblix
- ABL-001
- asciminibum
- Asciminib free base
- Asciminib?
- ABL001
- 1492952-76-7
- Asciminib [USAN]
- Example 9
- ABL001-NX
- NVP-ABL001
- Asciminib (Standard)
- Asciminib (ABL001)
- Asciminib hydrochloride
- ASCIMINIB [INN]
- RefChem:58302
- Asciminib (USAN/INN)
- ASCIMINIB [WHO-DD]
- ABL001-AAA
- L1F3R18W77
- C20H18ClF2N5O3
- UNII-L1F3R18W77
- VOVZXURTCKPRDQ-CQSZACIVSA-N
- ABL-001-NX
- GTPL8962
- orb1302024
- CHEMBL4208229
- SCHEMBL15388306
- SCHEMBL15388502
- TQP0925
- 1492952-76-7 (free base)
- EX-A3030
- BDBM50459091
- MFCD31560488
- NSC789925
- s8555
- Benzenesulfinic acid,2-amino-5-nitro
- AKOS032944882
- ZINC150275965
- AT30330
- CCG-269232
- compound 1 [PMID: 30137981]
- CS-7655
- DB12597
- EBC-171024
- HY-104010R
- NSC-789925
- BA166957
- BS-15538
- DA-50736
- SY041029
- HY-104010
- NS00073443
- J3.737.613B
- D11403
- (R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)nicotinamide
- A910986
- Q27074535
- 3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-
- N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
- B0084-007699
- 3-Pyridinecarboxamide, N-(4-(chlorodifluoromethoxy)phenyl)-6-((3R)-3-hydroxy-1-pyrrolidinyl)-5-(1H-pyrazol-3-yl)-
- (R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-3-yl)nicotinamide
- N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-3-yl)pyridine-3-carboxamide
- (R)-N-(4-(Chloro difluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)nicotinamide
- (R)-N-[4-(Chlorodifluoromethoxy)phenyl]-6-(3-hydroxy-1-pyrrolidinyl)-5-(3-pyrazolyl)nicotinamide
- Asciminib; 3-Pyridinecarboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-; N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-(1H-pyrazol-3-yl)-3-pyridinecarboxamide; 3-Pyridinecarboxamide N-[4-
- AY7
- N-(4-(chloro(difluoro)methoxy)phenyl)-6-((3R)-3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
- N-(4-(CHLORODIFLUOROMETHOXY)PHENYL)-6-((3R)-3- HYDROXYPYRROLIDIN-1-YL)-5-(1H-PYRAZOL-3-YL)PYRIDINE- 3-CARBOXAMIDE
- N-(4-(chlorodifluoromethoxy)phenyl)-6-((3R)-3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
- N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide